Infusion cell freezing medium and application thereof
The invention provides an infusion cell cryopreservation solution. The infusion cell cryopreservation solution comprises the following components in percentage by volume: 10% of glycerol; 20% of a human serum albumin injection; and the balance of hydroxyethyl starch 40 sodium chloride injection. Whe...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
01.04.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention provides an infusion cell cryopreservation solution. The infusion cell cryopreservation solution comprises the following components in percentage by volume: 10% of glycerol; 20% of a human serum albumin injection; and the balance of hydroxyethyl starch 40 sodium chloride injection. Wherein the human serum albumin injection contains human serum albumin with the mass ratio of 20%; the hydroxyethyl starch 40 sodium chloride injection comprises 60g/L of hydroxyethyl starch 40 and 9g/L of sodium chloride. The cell freezing medium capable of being infused does not contain dimethyl sulfoxide, clinical adverse reactions caused by dimethyl sulfoxide in a traditional cell freezing medium are avoided, and efficient, safe and stable cell freezing is achieved; in addition, the cell cryopreservation liquid capable of being infused can be used for clinical-grade cryopreservation of CAR-NK cells and can be directly infused after resuscitation.
本申请提供一种可输注细胞冻存液,其按体积百分比包含:甘油10%;人血白蛋白注射液20%;以及余量为羟乙基淀粉40氯化钠注射液;其中,所述 |
---|---|
Bibliography: | Application Number: CN202210026083 |